14. Heart Failure and Cardiomyopathies: Therapy 1089-09

1089-09 - CAUSES OF CARDIOVASCULAR HOSPITALIZATION AND DEATH IN THE TAFAMIDIS IN TRANSTHYRETIN CARDIOMYOPATHY CLINICAL TRIAL (ATTR-ACT)

Session
1089 - Cardiac Amyloidosis: Epidemiology and Outcomes
Speakers
Pathway
14. Heart Failure and Cardiomyopathies: Therapy
Presentation Number
1089-09
Presentation Rating
 |